IRCT20120731010453N5 IRCT 2023-07-04 Shiraz University of Medical Sciences continuous versus rapid infusion of albumin on the clinical outcomes of pediatric undergoing liver transplantation continuous versus rapid infusion of albumin on the clinical outcomes of pediatric undergoing liver transplantation, a randomized clinical trial. 2023-07-01 anticipated 42 Complete https://irct.ir/trial/70491 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: After liver transplant surgery, all eligible patients are divided into two groups of 21 people, intervention and control, using a random number table, permutation blocking method. This table was prepared by a biostatistician and the patients are divided into one of two groups receiving fast and slow albumin according to the order of sampling according to the table, Blinding description: The albumin prescription will be given by the gastroenterologist or pediatric special care specialist, and the head of the department, who does not have a role in the evaluation of results and data analysis, will assign the patients to It divides the above two groups, so the prescribing person as well as the researchers of this study are blinded in terms of what albumin regimen the patient receives. N/A liver transplantation. Intervention 1: Intervention group: They receive albumin at a dose of 0.5 to 1 g/kg slowly over 180 minutes. Intervention 2: Control group: They receive albumin at a dose of 0.5 to 1 g/kg rapidly for 30 minutes. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information